Related Experiment Video
Updated: Mar 1, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Genome Sequence of Escherichia coli E28, a Multidrug-Resistant Strain Isolated from a Chicken Carcass, and Its
Imke Schmidt1, Thomas Riedel2, Isabel Schober1
1Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.
Abstract:
In this study, we sequenced the complete genome of the multidrug-resistant Escherichia coli strain E28, which was used as an indicator strain for phage therapy in vivo We used a combination of single-molecule real-time and Illumina sequencing technology to reveal the presence of a spontaneously inducible prophage.
Insights
Researchers sequenced the multidrug-resistant Escherichia coli strain E28 genome. This revealed a spontaneously inducible prophage, important for phage therapy research in vivo.
Area of Science:
- Microbiology
- Genomics
- Bacteriophage Research
Background:
- Multidrug-resistant bacteria pose a significant global health threat.
- Phage therapy is an emerging alternative to antibiotics for bacterial infections.
- Characterizing bacterial genomes is crucial for understanding resistance mechanisms and developing targeted therapies.
Purpose of the Study:
- To perform a complete genome sequencing of the multidrug-resistant Escherichia coli strain E28.
- To identify genetic elements relevant to phage therapy applications.
Main Methods:
- Whole-genome sequencing using a combination of single-molecule real-time (SMRT) and Illumina technologies.
- Bioinformatic analysis for genome assembly and feature identification.
Main Results:
- The complete genome sequence of Escherichia coli strain E28 was successfully obtained.
- A spontaneously inducible prophage was identified within the E28 genome.
- Strain E28's genomic data provides a foundation for its use as an indicator strain in phage therapy studies.
Conclusions:
- The genomic characterization of Escherichia coli E28 provides valuable insights into its genetic makeup.
- The identified prophage is a key feature for future investigations in phage therapy efficacy.
- This study supports the use of strain E28 as a model organism for in vivo phage therapy research.
More Related Videos
Related Concept Videos
Single-Strand DNA Binding Proteins
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Lysogenic Cycle of Bacteriophages
DNA Bacteriophages
Viral Replication: Lytic Cycle
Stringent Response in E. coli

